Background: Propofol when administered by brief infusion in a lipid-fr
ee formulation has a slower onset, prolonged offset and greater potenc
y compared with an emulsion formulation. To understand these findings
the authors examined propofol brain and lung distribution kinetics in
rats. Methods: Rats were infused with equieffective doses of propofol
in emulsion (n = 21) or lipid-free formulation (n = 21). Animals were
sacrificed at various times to harvest brain and lung. Arterial blood
was sampled repeatedly from each animal until sacrifice. Deconvolution
and moment analysis were used to calculate the half-life for propofol
brain turnover (BT) and brain:plasma partition coefficient (Kp). Lung
concentration-time profiles were compared for the two formulations. R
esults: Peak propofol plasma concentrations for the lipid-free formula
tion were 50% of that observed for emulsion formulation, whereas peak
lung concentrations for lipid-free formulation were 300-fold higher th
an emulsion formulation. Brain Kp calculated from tissue disposition c
urve and ratio of brain:plasma area under the curves were 8.8 and 13,
and 7.2 and 9.1 for emulsion and lipid-free formulations, respectively
. BT were 2.4 and 2.5 min for emulsion and lipid-free formulations, re
spectively. Conclusions: Significant pulmonary sequestration and slow
release of propofol into arterial circulation when administered in lip
id-free vehicle accounts for the lower peak arterial concentration and
sluggish arterial kinetics relative to that observed with the emulsio
n formulation. Higher Kp for the lipid-free formulation could explain
the higher potency associated with this formulation. BT were independe
nt of formulation and correlated with values reported for effect-site
equilibration halftime consistent with a distribution mechanism for ph
armacologic hysteresis.